Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ortho Tri-Cyclen Pediatric Precaution Data Will Be Added To Label

Executive Summary

Ortho-McNeil is changing labeling for Ortho Tri-Cyclen to include information from its pediatric exclusivity study showing lack of significant effect on low mineral bone density in anorexic adolescent females

You may also be interested in...



BPCA Adverse Event Reports To Be Presented According To Three-Tier System

FDA has developed a three-tier system for its presentations of pediatric drug adverse event reports to its Pediatric Advisory Committee, as mandated by the Best Pharmaceuticals for Children Act

BPCA Adverse Event Reports To Be Presented According To Three-Tier System

FDA has developed a three-tier system for its presentations of pediatric drug adverse event reports to its Pediatric Advisory Committee, as mandated by the Best Pharmaceuticals for Children Act

Concerta Adverse Events Update On “Drug Watch” Web Site Advised By Cmte.

FDA should consider posting concerns about psychiatric and cardiovascular adverse events with Johnson & Johnson's Concerta and other methylphenidate products on the agency's upcoming "Drug Watch" website, members of FDA's Pediatric Advisory Committee said

Related Content

Topics

UsernamePublicRestriction

Register

PS046026

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel